Mallinckrodt Pharmaceuticals
MNK
#10255
Rank
โ‚น0.39 B
Marketcap
โ‚น29.56
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Mallinckrodt Pharmaceuticals (MNK)

EPS in 2023 (TTM): -โ‚น9,935

According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น10,520. In 2021 the company made an earnings per share (EPS) of -โ‚น735.92 an increase over its 2020 EPS that were of -โ‚น972.25.

EPS history for Mallinckrodt Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น9,935
2021-โ‚น735.92-24.31%
2020-โ‚น972.25-5.41%
2019-โ‚น1,028-72.67%
2018-โ‚น3,761-291.46%
2017โ‚น1,964797.22%
2016โ‚น218.95-34.03%
2015โ‚น331.90-207.61%
2014-โ‚น308.45-366.73%
2013โ‚น115.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น1,224-111.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น173.77-98.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚น742.88-107.06%๐Ÿ‡บ๐Ÿ‡ธ USA